| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
110.25(B) |
| Last
Volume: |
6,013,077 |
Avg
Vol: |
8,376,873 |
| 52
Week Range: |
$48.64 - $77.42 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
304,513 |
503,645 |
996,293 |
2,118,674 |
| Total Sell Value |
$22,679,618 |
$34,760,114 |
$60,765,476 |
$110,963,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
26 |
43 |
79 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nicholas Peter M |
Director |
– • – |
2009-12-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(88,951) |
11,674,494 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-12-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(422,095) |
17,812,686 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-12-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(421,033) |
11,763,445 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-11-13 |
4 |
S |
$8.25 |
$1,702,652 |
D/D |
(205,482) |
9,193,128 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-11-12 |
4 |
S |
$8.29 |
$1,243,995 |
D/D |
(150,000) |
9,398,610 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-11-11 |
4 |
S |
$8.34 |
$1,251,375 |
D/D |
(150,000) |
9,548,610 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-11-10 |
4 |
S |
$8.21 |
$1,230,855 |
D/D |
(150,000) |
9,698,610 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-11-09 |
4 |
S |
$8.12 |
$1,631,860 |
D/D |
(200,000) |
9,848,610 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-11-06 |
4 |
S |
$8.08 |
$1,211,940 |
D/D |
(150,000) |
10,048,610 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-11-05 |
4 |
S |
$7.94 |
$2,000,540 |
D/D |
(250,000) |
10,198,610 |
|
- |
|
| Kucheman William |
SVP & Group President |
• – – |
2009-11-02 |
4 |
D |
$8.21 |
$16,945 |
D/D |
(2,064) |
36,993 |
|
- |
|
| Kucheman William |
SVP & Group President |
• – – |
2009-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
39,057 |
|
- |
|
| Mcfaul David W |
Senior VP International |
• – – |
2009-11-02 |
4 |
D |
$8.21 |
$6,896 |
D/D |
(840) |
39,692 |
|
- |
|
| Mcfaul David W |
Senior VP International |
• – – |
2009-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,645 |
40,532 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
100,000 |
12,184,478 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
225,000 |
4,237,749 |
|
- |
|
| Pucel Kenneth |
EVP, Operations |
• – – |
2009-11-02 |
4 |
D |
$8.21 |
$16,945 |
D/D |
(2,064) |
50,492 |
|
- |
|
| Pucel Kenneth |
EVP, Operations |
• – – |
2009-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
52,556 |
|
- |
|
| Mcfaul David W |
Senior VP International |
• – – |
2009-10-30 |
4 |
D |
$8.12 |
$24,060 |
D/D |
(2,963) |
37,887 |
|
- |
|
| Mcfaul David W |
Senior VP International |
• – – |
2009-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,332 |
40,850 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2009-10-30 |
4 |
D |
$8.12 |
$8,510 |
D/D |
(1,048) |
19,328 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2009-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,290 |
20,376 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-10-29 |
4 |
S |
$8.21 |
$410,280 |
I/I |
(50,000) |
12,084,478 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-10-29 |
4 |
S |
$8.21 |
$1,029,143 |
I/I |
(125,000) |
4,012,749 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-10-28 |
4 |
S |
$8.22 |
$411,075 |
I/I |
(50,000) |
12,134,478 |
|
- |
|
2009 Records found
|
|
Page 56 of 81 |
|
|
0.41 (0.53%) 
